New double-drug “wonder” therapy reignites hope of boosting lung cancer patients’ survival

Recently published trial results of a lung cancer treatment have become a center of attention and many experts are claiming it to be a “quantum leap” forward in cancer diagnosis and treatment. The immunotherapy medicine, nivolumab, is a new double-drug therapy that can reduce the risk of relapse and increase the chances of survival by … Read more